These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32406133)

  • 1. Metabolic modulation during intestinal fibrosis.
    Bos S; Laukens D
    J Dig Dis; 2020 Jun; 21(6):319-325. PubMed ID: 32406133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis.
    Hünerwadel A; Fagagnini S; Rogler G; Lutz C; Jaeger SU; Mamie C; Weder B; Ruiz PA; Hausmann M
    Sci Rep; 2018 Oct; 8(1):15182. PubMed ID: 30315190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease.
    Lawrance IC; Maxwell L; Doe W
    Inflamm Bowel Dis; 2001 Aug; 7(3):226-36. PubMed ID: 11515849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of non-inflammatory factors in intestinal fibrosis.
    Zhao JF; Ling FM; Li JR; Chen YD; Huang L; Zhu LR
    J Dig Dis; 2020 Jun; 21(6):315-318. PubMed ID: 32406603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiome.
    Jacob N; Jacobs JP; Kumagai K; Ha CWY; Kanazawa Y; Lagishetty V; Altmayer K; Hamill AM; Von Arx A; Sartor RB; Devkota S; Braun J; Michelsen KS; Targan SR; Shih DQ
    Mucosal Immunol; 2018 Sep; 11(5):1466-1476. PubMed ID: 29988118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease.
    Bamias G; Pizarro TT; Cominelli F
    Inflamm Bowel Dis; 2022 Mar; 28(3):337-349. PubMed ID: 34904152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts.
    Johnson LA; Rodansky ES; Sauder KL; Horowitz JC; Mih JD; Tschumperlin DJ; Higgins PD
    Inflamm Bowel Dis; 2013 Apr; 19(5):891-903. PubMed ID: 23502354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of initiation and progression of intestinal fibrosis in IBD.
    Latella G; Di Gregorio J; Flati V; Rieder F; Lawrance IC
    Scand J Gastroenterol; 2015 Jan; 50(1):53-65. PubMed ID: 25523556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing fibrosis in IBD: update on immune pathways and clinical strategies.
    Wang J; Yang B; Chandra J; Ivanov A; Brown JM; Rieder F
    Expert Rev Clin Immunol; 2024 Jul; 20(7):727-734. PubMed ID: 38475672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models.
    Pucilowska JB; Williams KL; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2000 Oct; 279(4):G653-9. PubMed ID: 11005750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease.
    Lovisa S; Genovese G; Danese S
    J Crohns Colitis; 2019 Apr; 13(5):659-668. PubMed ID: 30520951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we prevent, reduce or reverse intestinal fibrosis in IBD?
    Latella G; Sferra R; Speca S; Vetuschi A; Gaudio E
    Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1283-304. PubMed ID: 23740440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease.
    Ferrer-Picón E; Dotti I; Corraliza AM; Mayorgas A; Esteller M; Perales JC; Ricart E; Masamunt MC; Carrasco A; Tristán E; Esteve M; Salas A
    Inflamm Bowel Dis; 2020 Jan; 26(1):43-55. PubMed ID: 31211831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadherin-11 Is a Regulator of Intestinal Fibrosis.
    Franzè E; Monteleone I; Laudisi F; Rizzo A; Dinallo V; Di Fusco D; Colantoni A; Ortenzi A; Giuffrida P; Di Carlo S; Sica GS; Di Sabatino A; Monteleone G
    J Crohns Colitis; 2020 Mar; 14(3):406-417. PubMed ID: 31504344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation.
    Scheibe K; Kersten C; Schmied A; Vieth M; Primbs T; Carlé B; Knieling F; Claussen J; Klimowicz AC; Zheng J; Baum P; Meyer S; Schürmann S; Friedrich O; Waldner MJ; Rath T; Wirtz S; Kollias G; Ekici AB; Atreya R; Raymond EL; Mbow ML; Neurath MF; Neufert C
    Gastroenterology; 2019 Mar; 156(4):1082-1097.e11. PubMed ID: 30452921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic insights on the metabolism in inflammatory bowel disease.
    Pisani LF; Moriggi M; Gelfi C; Vecchi M; Pastorelli L
    World J Gastroenterol; 2020 Feb; 26(7):696-705. PubMed ID: 32116417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diet in Intestinal Fibrosis: A Double-Edged Sword.
    Marion-Letellier R; Leboutte M; Amamou A; Raman M; Savoye G; Ghosh S
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changing paradigm in the management of inflammatory bowel disease].
    Jang BI
    Korean J Gastroenterol; 2015 May; 65(5):268-72. PubMed ID: 25998972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal fibrosis in IBD--a dynamic, multifactorial process.
    Rieder F; Fiocchi C
    Nat Rev Gastroenterol Hepatol; 2009 Apr; 6(4):228-35. PubMed ID: 19347014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.